Zobrazeno 11 - 20
of 117
pro vyhledávání: '"Kiyonaga Fujii"'
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure Legends 1-7 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa943836f1f84b92997a426bd7bda0a2
https://doi.org/10.1158/1078-0432.22441897
https://doi.org/10.1158/1078-0432.22441897
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 5 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a05c6f02a316086eb5dc3bd3c21e4f50
https://doi.org/10.1158/1078-0432.22441906.v1
https://doi.org/10.1158/1078-0432.22441906.v1
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Purpose: We aimed to identify candidate proteins for tumor markers to predict the response to gefitinib treatment.Experimental Design: We did two-dimensional difference gel electrophoresis to create the protein expression profile of lung adenocarcino
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d84216713e7479a2bf95563cd4b62fa5
https://doi.org/10.1158/1078-0432.c.6518773
https://doi.org/10.1158/1078-0432.c.6518773
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Table 1 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c57b158ac625fced3697e2772e42455
https://doi.org/10.1158/1078-0432.22441894.v1
https://doi.org/10.1158/1078-0432.22441894.v1
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 7 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3da685edaebf05206430acb218007f
https://doi.org/10.1158/1078-0432.22441900
https://doi.org/10.1158/1078-0432.22441900
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Table 3 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::337a53dbf073ae7e8c7516369b0bf31d
https://doi.org/10.1158/1078-0432.22441888.v1
https://doi.org/10.1158/1078-0432.22441888.v1
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Figure 6 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ef1a9ce8358c0791356aa09217100f2
https://doi.org/10.1158/1078-0432.22441903.v1
https://doi.org/10.1158/1078-0432.22441903.v1
Autor:
Setsuo Hirohashi, Shoji Kudoh, Harbumi Kato, Akihiko Gemma, Yoshihiro Matsuno, Koji Tsuta, Yuichiro Ohe, Toshimi Takano, Toshihide Nishimura, Kiyonaga Fujii, Tadashi Kondo, Tetsuya Okano
Supplementary Table 2 from Proteomic Signature Corresponding to the Response to Gefitinib (Iressa, ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aff2cf2fd4213f89415860c6bc6243c2
https://doi.org/10.1158/1078-0432.22441891
https://doi.org/10.1158/1078-0432.22441891
Autor:
Takayuki Koga, Kie Inoue, Fuka Hirayama, Makoto Hiromura, Kiyonaga Fujii, Yuji Ishii, Masayo Hirao-Suzuki, Shuso Takeda, Akihisa Toda, Fumio Soeda
Publikováno v:
Biological and Pharmaceutical Bulletin.
Autor:
Toshihide Nishimura, Haruhiko Nakamura, Kiyonaga Fujii, Hiroki Sakai, Saeko Naruki, Naoki Furuya, Harubumi Kato, Hisashi Saji
Micropapillary- and solid-predominant lung adenocarcinomas (MPA and SPA), high-risk subtypes with poor outcomes, remain their molecular profiles unclarified. This study aimed at identifying the disease-related protein networks associated with early-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e364510607f917b015a138fffc6ffc75
https://doi.org/10.21203/rs.3.rs-2377717/v1
https://doi.org/10.21203/rs.3.rs-2377717/v1